Search by Drug Name or NDC

    NDC 00093-8311-18 Eletriptan Hydrobromide 40 mg/1 Details

    Eletriptan Hydrobromide 40 mg/1

    Eletriptan Hydrobromide is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Teva Pharmaceuticals USA, Inc.. The primary component is ELETRIPTAN HYDROBROMIDE.

    Product Information

    NDC 00093-8311
    Product ID 0093-8311_6b8e7aca-1ec4-445a-ac2e-87cfef15c6f4
    Associated GPIs 67406025100340
    GCN Sequence Number 049606
    GCN Sequence Number Description eletriptan hydrobromide TABLET 40 MG ORAL
    HIC3 H3F
    HIC3 Description ANTIMIGRAINE PREPARATIONS
    GCN 15174
    HICL Sequence Number 023093
    HICL Sequence Number Description ELETRIPTAN HYDROBROMIDE
    Brand/Generic Generic
    Proprietary Name Eletriptan Hydrobromide
    Proprietary Name Suffix n/a
    Non-Proprietary Name Eletriptan Hydrobromide
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 40
    Active Ingredient Units mg/1
    Substance Name ELETRIPTAN HYDROBROMIDE
    Labeler Name Teva Pharmaceuticals USA, Inc.
    Pharmaceutical Class Serotonin 1b Receptor Agonists [MoA], Serotonin 1d Receptor Agonists [MoA], Serotonin-1b and Serotonin-1d Receptor Agonist [EPC]
    DEA Schedule n/a
    Marketing Category ANDA
    Application Number ANDA202040
    Listing Certified Through 2024-12-31

    Package

    NDC 00093-8311-18 (00093831118)

    NDC Package Code 0093-8311-18
    Billing NDC 00093831118
    Package 6 BLISTER PACK in 1 CARTON (0093-8311-18) / 1 TABLET, FILM COATED in 1 BLISTER PACK (0093-8311-19)
    Marketing Start Date 2017-07-21
    NDC Exclude Flag N
    Pricing Information
    Price Per Unit 2.37315
    Pricing Unit EA
    Effective Date 2024-02-21
    NDC Description ELETRIPTAN HBR 40 MG TABLET
    Pharmacy Type Indicator C/I
    OTC N
    Explanation Code 1
    Classification for Rate Setting G
    As of Date 2024-02-21
    This pricing file, entitled the NADAC (National Average Drug Acquisition Cost) files, provide state Medicaid agencies with covered outpatient drug prices by averaging survey invoice prices from retail community pharmacies across the United States. These pharmacies include independent retail community pharmacies and chain pharmacies. The prices are updated on a weekly and monthly basis